2008: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis
Search or Browse by Day

Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Tuesday, October 28, 2008
1546
Helicobacter Pylori Infection and Gastrointestinal Intolerance to Oral Bisphosphonates
1547
Hip Strength Estimates by Finite Element Analysis and Prediction of Prevalent Fractures in Women and Men
1548
Fracture Incidence, Quality of Life and Back Pain in Women with Osteoporosis Pretreated with Bisphosphonates: 18 Month Results from the European Forsteo Observational Study (EFOS)
1549
Treatment of Osteoporotic Women with Parathyroid Hormone (1-84) for 24 Months Improves Cancellous Bone Formation and Structure: A Bone Biopsy Study
1550
Association of the A1330V Polymorphism of Low-density Lipoprotein Receptor-related Protein 5 Gene with Serum Total Cholesterol Level and Incident Fractures in Japanese Female Patients with Rheumatoid Arthritis
1551
Efficacy Of The Vitamin D Supplementation In Patients With Hypovitaminosis D And Secondary Hyperparathyroidism
1552
Musculoskeletal Pain among Patients on Bisphosphonates: A Possible Adverse Drug Event
1553
The Cost-Effectiveness of a Multi-modal Intervention for the Prevention of Glucocorticoid-Induced Osteoporosis
1554
Risk of Hip Fracture after Bisphosphonate Discontinuation: Implications for a Drug Holiday
1555
“Pathologic” Fractures: To Include or Exclude?
1556
Do Physicians Who Practice Together Provide Similar Osteoporosis Care?
1557
Effects of Androgen Deprivation Therapy on Bone Health in Prostate Cancer
1558
Outcomes after Switching from One Bisphosphonate to Another in 146 Patients at a Single University Hospital
1559
Risk Factors For Subsequent Fractures Within One Year In Patients Presenting With A Clinical Vertebral Or Non-vertebral Fracture
1560
An Under-recognized Hazard - Exponential Increase In Prevalence Rates Of Osteoporotic Fractures In Aging Men Parallels That Of Women
1561
Initiation and Adherence with Osteoporosis Therapy
1562
Relationship between 3-month Changes in Biochemical Markers of Bone Remodelling and 3-year Changes in Bone Mineral Density in Patients Treated with Strontium Ranelate
1563
Association between Changes in Bone Mineral Density and Fracture Incidence in Postmenopausal Osteoporotic Women Receiving Calcium and Vitamin D: a 3-year Follow-up Study
1564
The Impact of Rib Fractures on Health Related Quality of Life is Underestimated
1565
Hip Bone Mineral Density and Vascular Calcification in Elderly People Community-Dwelling
1566
Ten Year Probability of Hip Fracture Risk in a Cohort of Elderly Male Veterans
1567
The Osteoporosis Self Assessment Tool in U.S. Male Veterans
1568
Decreased Sensitivity of Posterior-Anterior (PA) DXA Scans in Older Men is Related to Degenerative Artifacts and Pathology
1569
Acute Phase Response after Administration of Intravenous Bisphosphonate in Osteoporotic Patients with Rheumatism
1570
Evaluation of Zoledronate’s Efficacy and Safety in the Treatment of Paget’s Disease
1571
Low Bone Mineral Density (BMD) and Dysautonomia in Adolescents and Young Patients with Ehlers-Danlos Syndrome, Hypermobile Type: Clinical Study of 90 Patients
1572
Absolute Death Rates by Fracture Type in Canadians
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>